Proventis Pharmaceuticals Private Limited
About Proventis Pharmaceuticals Private Limited
Data last updated:
Proventis Pharmaceuticals Private Limited is a private limited company based in Jaipur, Rajasthan, India. It operates in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 11 October 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U24232RJ2005PTC021441. Its GSTIN is 08AADCP7091G1Z7 (Rajasthan).
The company has an authorised share capital of ₹4 Lakh and a paid-up capital of ₹4 Lakh. It is led by directors Manisha Puri and Rajiv Puri.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 195 Gom Defence Colony Vaishali Nagar, Jaipur, Rajasthan, India.
As per the financials filed for FY 2025, the company reported a revenue of ₹36.46 Lakh, a growth of 4% compared to the previous year. For the same year it recorded a net profit of ₹14,626 (net margin 0.4%) and EBITDA of ₹2.25 Lakh (EBITDA margin 6.2%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 1% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address195 Gom Defence Colony Vaishali Nagar, Jaipur, Rajasthan, India
- IndustryTrading, Wholesale, Other Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Proventis Pharmaceuticals Private Limited
The main business activity of Proventis Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Proventis Pharmaceuticals Private Limited FY 2025 filings available
Proventis Pharmaceuticals Private Limited reported revenue of ₹36.46 Lakh (up 4% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Proventis Pharmaceuticals Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 1% over five years, including 4% growth in the latest year. EBITDA fell 19% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Proventis Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹2.25 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹14,626 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Proventis Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Proventis Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Proventis Pharmaceuticals Private Limited
Proventis Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Beactive Pharmaceuticals Private Limited | ₹36.65 Lakh (FY 2024) | •••• | •••• | 85.0% | •••• | Ambala, Haryana, India |
| Achala Pharmaceuticals Pvt Ltd | ₹36.64 Lakh (FY 2024) | •••• | •••• | -3.0% | •••• | Navi Mumbai, Maharashtra, India |
| Medgaraz Pharmaceuticals Private Limited | ₹36.58 Lakh (FY 2025) | •••• | •••• | 1266.0% | •••• | Jabalpur, Madhya Pradesh, India |
| Kovish Pharmaceuticals Private Limited | ₹36.54 Lakh (FY 2025) | •••• | •••• | 14.0% | •••• | New Delhi, Delhi, India |
| Health Secure Pharmaceuticals (India) Private Limited | ₹36.48 Lakh (FY 2021) | •••• | •••• | 0.0% | •••• | Nashik, Maharashtra, India |
| Proventis Pharmaceuticals Private Limited this company | ₹36.46 Lakh (FY 2025) | •••• | •••• | 4.0% | •••• | Jaipur, Rajasthan, India |
| Wellrick Pharmaceuticals Private Limited | ₹36.34 Lakh (FY 2024) | •••• | •••• | •••• | Ahmedabad, Gujarat, India | |
| Clarsun Pharmaceuticals Private Limited | ₹36.29 Lakh (FY 2024) | •••• | •••• | -18.0% | •••• | Hyderabad, Telangana, India |
| Artifex Pharmaceuticals Private Limited | ₹36.23 Lakh (FY 2024) | •••• | •••• | -3.0% | •••• | Kolhapur, Maharashtra, India |
| Motto Pharmaceuticals Private Limited | ₹36.19 Lakh (FY 2024) | •••• | •••• | 61.0% | •••• | New Delhi, Delhi, India |
| Grampus Pharmaceuticals Private Limited | ₹36.17 Lakh (FY 2025) | •••• | •••• | 452.0% | •••• | Haryana, India |
Peers are the five companies nearest above and the five nearest below Proventis Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Proventis Pharmaceuticals Private Limited
Proventis Pharmaceuticals Private Limited is audited by ARPIT VIJAY & COMPANY for the financial year 2017.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| ARPIT VIJAY & COMPANY | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Proventis Pharmaceuticals Private Limited
Proventis Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manisha Puri | Director | 22 Apr 2010 | 16 Years 5 Months | Current |
| Rajiv Puri | Director | 11 Oct 2005 | 20 Years 11 Months | Current |
Ownership and Shareholding of Proventis Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Proventis Pharmaceuticals Private Limited
Proventis Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Proventis Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Proventis Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Proventis Pharmaceuticals Private Limited
Proventis Pharmaceuticals Private Limited has 4 board changes on record since 2005: 2 appointments and 2 cessations. The latest: Lokesh Parashar ceased to be Director on 28 Apr 2010.
Credit Ratings, Litigation & Regulatory Alerts for Proventis Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Proventis Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Proventis Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Proventis Pharmaceuticals Private Limited
Proventis Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AADCP7091G1Z7 | Rajasthan | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Proventis Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Proventis Pharmaceuticals Private Limited
Proventis Pharmaceuticals is an active private limited company based in Jaipur, Rajasthan, India. The company works in wholesale, within the trading industry. It was incorporated on 11 October 2005 (21+ years old) and is registered under CIN U24232RJ2005PTC021441.
Proventis Pharmaceuticals reported revenue of ₹36.46 Lakh for FY 2025 (up 4% YoY).
Proventis Pharmaceuticals has 2 current directors:
- Manisha Puri - Director
- Rajiv Puri - Director
Proventis Pharmaceuticals reported a net profit of ₹14,626 (net margin 0.4%) and EBITDA of ₹2.25 Lakh (EBITDA margin 6.2%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Proventis Pharmaceuticals is 1% over three years and 1% over five years. In the latest year (FY 2025) revenue rose 4%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Proventis Pharmaceuticals is 08AADCP7091G1Z7, registered in Rajasthan.
The CIN (Corporate Identification Number) of Proventis Pharmaceuticals is U24232RJ2005PTC021441. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Proventis Pharmaceuticals was incorporated on 11 October 2005, making it 21+ years old. It is registered with the Registrar of Companies, Jaipur.
The peers of Proventis Pharmaceuticals by revenue are Beactive Pharmaceuticals Private Limited, Achala Pharmaceuticals Pvt Ltd, Medgaraz Pharmaceuticals Private Limited, Kovish Pharmaceuticals Private Limited, Health Secure Pharmaceuticals (India) Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Lokesh Parashar ceased to be Director on 28 Apr 2010. Manisha Puri was appointed as Director on 22 Apr 2010. Pradeep Kumar Sharma ceased to be Director on 06 Jul 2009. Proventis Pharmaceuticals has 4 board changes on record in total.
The registered office of Proventis Pharmaceuticals is at 195 Gom Defence Colony Vaishali Nagar, Jaipur, Rajasthan, India.